{"DataElement":{"publicId":"1292","version":"5","preferredName":"Laboratory Procedure Baseline Prostate-Specific Antigen Outcome Value","preferredDefinition":"the lab value for Prostate-Specific Antigen measured according to a standardized test.  The baseline PSA is the most recent value within 8 weeks prior to enrollment on a clinical trial.  The level of PSA in the serum can be used to gauge tumor response to treatment, detect the presence of persistent tumor, or indicate the recurrence of cancer or development of new metastasis.","longName":"LAB_BSL_PSA_OC_VAL","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2188793","version":"1","preferredName":"Laboratory Procedure Baseline Prostate-Specific Antigen Outcome","preferredDefinition":"information related to medical test results for a tissue kallikrein-related sequence enzyme used as a biomarker for prostate cancer available before study treatment begins.","longName":"LAB_BSL_PSA_OC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2763277","version":"1","preferredName":"Baseline PSA Outcome","preferredDefinition":"Baseline; an imaginary standard by which things are measured or compared.:Alternate isoforms of the single-chain 261-aa 30-kD Kallikrein 3 (Prostate Specific Antigen) glycoprotein precursor are encoded by human KLK3 Gene (Kallikrein Family). Frameshifted isoform 2 has a shorter distinct C-terminus. A serine protease in seminal plasma, PSA may function in liquefaction of seminal coagulum by (preferential Tyr-X) cleavage of seminal vesicle protein. Kallikrein proteases have diverse functions. Mounting evidence implicates kallikreins in carcinogenesis; some have potential as cancer biomarkers. The serum level of PSA is useful in diagnosis and monitoring of prostatic carcinoma. (from LocusLink, Swiss-Prot, OMIM, and NCI):Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C25213:C17525:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Baseline","conceptCode":"C25213","definition":"A starting point to which things may be compared.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prostate-Specific Antigen","conceptCode":"C17525","definition":"Prostate-specific antigen (261 aa, ~29 kDa) is encoded by the human KLK3 gene. This protein plays a role in both proteolysis and seminal fluid liquefaction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5187EE86-B585-5DB0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-08","modifiedBy":"ONEDATA","dateModified":"2008-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E561DDDD-9F29-23CA-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2019133","version":"2","preferredName":"PSA Lab Value","preferredDefinition":"a PSA (prostate specific antigen) laboratory value.","longName":"PSA_LAB_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"ng/ml","minLength":"1","maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":"3","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184351","version":"1","preferredName":"Value","preferredDefinition":"Value; a numerical quantity measured or assigned or computed.","longName":"Value","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2187-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5514211A-9990-0C4B-E053-F662850A73A5","latestVersionIndicator":"Yes","beginDate":"2017-07-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2017-07-24","modifiedBy":"CAMPBELB","dateModified":"2017-07-24","changeDescription":"released, decimal place value added","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811916","version":"1","longName":"Localized Prostate","context":"CTEP"},{"publicId":"2811920","version":"1","longName":"Non-local Prostate","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171065","version":"1","longName":"RTOG-0924","context":"NRG"},{"publicId":"4171064","version":"1","longName":"RTOG-0815","context":"NRG"},{"publicId":"4171063","version":"1","longName":"RTOG-0534","context":"NRG"}]}],"AlternateNames":[{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"LB_LBORRES_PSA_BL","type":"OID, CCTG","context":"CCTG"},{"name":"SERUM_PSA_VAL","type":"DCP Alt Name","context":"DCP"}],"ReferenceDocuments":[{"name":"Baseline PSA Value","type":"Preferred Question Text","description":"Baseline PSA Value","url":null,"context":"CTEP"},{"name":"COMMENT_203","type":"COMMENT","description":"Instruction on template form: (per protocol definition)","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Baseline PSA Value","url":null,"context":"CTEP"},{"name":"2-COMMENT","type":"COMMENT","description":"Units of measure shown on template form include: n/mg, ng/mL, U/L, mg/L, ng/dL, mcg/L","url":null,"context":"CTEP"},{"name":"Baseline PSA","type":"Alternate Question Text","description":"PSA value at study entry","url":null,"context":"ECOG-ACRIN"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Baseline PSA Value (ng/ml)","url":null,"context":"CCTG"},{"name":"DCP-Text-1","type":"Alternate Question Text","description":"Serum PSA (ng/mL)","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"551436FE-F5D0-2BF8-E053-F662850AFC42","latestVersionIndicator":"Yes","beginDate":"2017-07-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2017-07-24","modifiedBy":"MMADDINENI","dateModified":"2024-01-15","changeDescription":"ISO 11179 Compliance","administrativeNotes":"12023.11.22 AQT added per ticket request CADSR0003107. ak  1/16/23 Added alt OID for CCTG ticket number CADSR0003085 cjl","unresolvedIssues":null,"deletedIndicator":"No"}}